Pro 2013-018 (Jianfeng Group's Announcement on Issuance of Corporate Bonds in 2013)-3
Release time:
2020-08-05
16 , debt service method: using single interest on an annual basis, excluding compound interest, overdue no additional interest. Interest is paid once a year, the principal is repaid once due, and the last interest is paid with the payment of the principal. If the bondholder exercises the resale option at the end of 3 , the face value of the resale portion of the bond plus the interest for year 3 will be paid together on the investor's resale payment date.
17 , principal payment date: 2018 6 July 5 (in case of legal holidays or rest days, it will be postponed to the following working days). If the investor exercises the option of resale, the payment date of part of the bonds sold back will be 2016 6 May 5 (in case of legal holidays or rest days, it will be postponed to the following 1 working days).
18 , Guarantee: This corporate bond is provided by Tianjin Tianshili Group Co., Ltd. with full unconditional and irrevocable joint and several liability guarantee .
19 , credit rating, credit rating agency and follow-up rating arrangement: is comprehensively assessed by United Credit Rating Co., Ltd. , the credit rating of the current corporate bonds is AA + , and the main credit rating of the issuer is AA .
According to the relevant regulations of the regulatory authorities and the relevant requirements of United Rating for tracking rating, United Rating will conduct a regular tracking rating on this bond within 2 months after the issuer announces the annual report each year during the effective duration of this bond, and will conduct a regular tracking rating on according to relevant conditions during the duration of this bond.
The issuer shall provide relevant financial reports and other relevant information as required by the Joint Rating Tracking Rating Information List. The issuer shall promptly notify the joint rating and provide relevant information in the event of major changes or major events that may have a significant impact on the credit rating.
20 , Purpose of raising funds: This issue of corporate bonds is intended to be used to repay part of the company's debt and replenish the company's liquidity.
21 , Sponsor, Lead Underwriter, Bond Trustee: Zheshang Securities Co.
22 , underwriting method: is organized by the lead underwriter to underwrite the underwriting group, is underwritten by balance underwriting for the part that is finally undersubscribed for less than .1 billion yuan.
23 , proposed place of listing: Shanghai Stock Exchange.
24 , Listing Arrangements: After the issuance, the issuer will apply to the SSE for the listing and trading of the bonds as soon as possible. Specific listing time will be announced separately.
25 , new pledge repurchase: the long-term credit rating of the issuer is AA , and the credit rating of the current bond is AA + , which meets the basic conditions for conducting new pledge repurchase transactions. the relevant application for new pledge repurchase of the current bond still needs the final approval of the relevant departments, and the specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of the registered company.
26 , Tax Tips: According to the relevant national tax laws and regulations, the tax payable by investors investing in this bond shall be borne by the investors.
27 , Timing related to the issuance of this bond:
Trading Day |
Work Items |
T-2 Day ( 201 3 6 July 3 Day) |
Published Prospectus and Its Summary, Issue Announcement , Credit Rating Report |
T-1 ( 201 3 March 4 ) |
Offline Inquiry Determines Par Rate |
T Day ( 201 3 Year 6 September 5 Day) |
Announces Final Par Rate Online Subscription Date Offline Subscription Start Date Remaining Part of Online Subscription Dial Back to Offline Issuance (If Any) |
T +1 Date ( 201 3 6 April 6 Day) |
Offline Subscription Day |
T +2 Day ( 201 3 6 August 7 Day) |
Offline Subscription Deadline all investors subscribed offline on the day of shall not be later than the day of 1 6 : before 00 , the subscription money will be transferred to the special collection account |
T +3 ( 201 3 6 January 13 ) |
offline issue registration date, the lead underwriter will register the offline subscription data on the day 10: before 30 , submit it in written and electronic data to Shanghai Stock Exchange to publish the release results announcement |
T +4 ( 201 3 6 October 14 ) |
sponsor (lead underwriter) transfers money to issuer, issue ends |
Note: the above date is the trading day. In the event of a major emergency affecting the issuance, the issuer and the sponsor (lead underwriter) will promptly announce and modify the issuance schedule.
2. Offline Interest Rate Inquiry to Institutional Investors
1 , Offline Investors
This offline interest rate inquiry is aimed at institutional investors (except those prohibited by laws and regulations) who have opened qualified securities accounts in registered Company .
2 , interest rate inquiry interval and coupon rate determination method
The coupon rate inquiry interval of this bond is 4.60 - 5.40 , The final coupon rate is determined by the issuer and the sponsor (lead underwriter) within the above interest rate inquiry interval according to the offline inquiry results, fixed for the duration of the bond. The bonds bear interest on an annual basis at simple interest, excluding compound interest, and interest is not charged for overdue periods. The coupon rate of the current bond is fixed for the first 3 years of the bond's life. If the issuer exercises the option to increase the coupon rate, the annual coupon rate for 2 years after the duration of the bonds that have not been resold will be 3 year coupon rate plus the adjustment basis point before the duration of the bonds, and will be fixed for 2 years after the duration of the bonds. If the issuer does not exercise the option to increase the coupon rate, the coupon rate of the portion of the bonds that have not been resold will remain unchanged after the duration of the 2 .
3 , Inquiry Time
The offline interest rate inquiry time for this issue of bonds is 201 3 6 4 ( T-1 ), institutional investors participating in the inquiry must be on 201 3 6 4 ( T-1 ) 10 : 00 - 15:00 faxes the "Application Form for Offline Interest Rate Inquiry and Application for Purchase" (see Schedule 1) to the sponsor (lead underwriter).
4, Inquiry Method
(1 ) Fill in the Application Form for Offline Interest Rate Inquiry and Application Purchase
Institutional investors who intend to participate in offline inquiry and subscription can download the Application Form for Offline Interest Rate Inquiry andApplication Purchase from the website listed in the issuance announcement (see schedule) , and fill in correctly as required.
should pay attention to filling in the "Application Form for Offline Interest Rate Inquiry andApplication for 421 Purchase": ① should fill in the inquiry interest rate
within the interest rate inquiry range specified in the issuance announcement, and the inquiry interest rate may not be continuous; ② Each "Application Form for Online Interest Rate Inquiry and
Application forPurchase" can fill in up to 5 inquiry interest rates; ③ When filling in the inquiry interest rate, it is accurate to
0.01%; ④ Fill in the inquiry interest rate from low to high and in sequence;
⑤ The total subscription amount at each inquiry interest rate shall not be less than
100.46 million yuan (including 100 .48 million yuan) and shall be an integer multiple of 100 .5 million yuan (1,000 hands); ⑥ The total subscription amount corresponding to each inquiry interest rate is when the finally determined coupon rate is not lower than the inquiry interest rate, maximum investment demand of institutional investors
.(
2) Institutional investors who submit to participate in the inquiry should be on
2013 September 4
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31